SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-135972
Filing Date
2015-04-17
Accepted
2015-04-17 16:54:08
Documents
8
Period of Report
2015-05-28
Effectiveness Date
2015-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d890286ddef14a.htm DEF 14A 609816
2 GRAPHIC g890286appc_1a.jpg GRAPHIC 2939
3 GRAPHIC g890286appc_1b.jpg GRAPHIC 6907
4 GRAPHIC g890286appc_1c.jpg GRAPHIC 3421
5 GRAPHIC g890286appc_1d.jpg GRAPHIC 677
6 GRAPHIC g890286appc_1e.jpg GRAPHIC 968
7 GRAPHIC g890286appc_1f.jpg GRAPHIC 1026
8 GRAPHIC g890286g54z95.jpg GRAPHIC 9797
  Complete submission text file 0001193125-15-135972.txt   647367
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21990 | Film No.: 15778767
SIC: 2836 Biological Products, (No Diagnostic Substances)